Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poh, C. F.
Right arrow Articles by Rosin, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poh, C. F.
Right arrow Articles by Rosin, M. P.
Related Collections
Right arrowCommentary
Clinical Cancer Research Vol. 12, 6716-6722, November 15, 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients

Catherine F. Poh1,2,3, Lewei Zhang1, Don W. Anderson5, J. Scott Durham5, P. Michele Williams1,3, Robert W. Priddy1, Ken W. Berean6, Samson Ng1, Olivia L. Tseng7, Calum MacAulay4 and Miriam P. Rosin2,7

Authors' Affiliations: 1 Faculty of Dentistry, University of British Columbia, Departments of 2 Cancer Control Research, 3 Oral Oncology, and 4 Cancer Imaging, British Columbia Cancer Agency, Departments of 5 Surgery (Otolaryngology) and 6 Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada, and 7 School of Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada

Requests for reprints: Miriam P. Rosin, BC Oral Cancer Prevention Program, BC Cancer Agency/Cancer Control Research Centre, 675 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L3. Phone: 604-675-8078; Fax: 604-675-8180; E-mail: Miriam_Rosin{at}shaw.ca.

Purpose: Genetically altered cells could become widespread across the epithelium of patients with oral cancer, often in clinically and histologically normal tissue, and contribute to recurrent disease. Molecular approaches have begun to yield information on cancer/risk fields; tissue optics could further extend our understanding of alteration to phenotype as a result of molecular change.

Experimental Design: We used a simple hand-held device in the operating room to directly visualize subclinical field changes around oral cancers, documenting alteration to fluorescence. A total of 122 oral mucosa biopsies were obtained from 20 surgical specimens with each biopsy being assessed for location, fluorescence visualization (FV) status, histology, and loss of heterozygosity (LOH; 10 markers on three regions: 3p14, 9p21, and 17p13).

Results: All tumors showed FV loss (FVL). For 19 of the 20 tumors, the loss extended in at least one direction beyond the clinically visible tumor, with the extension varying from 4 to 25 mm. Thirty-two of 36 FVL biopsies showed histologic change (including 7 squamous cell carcinoma/carcinomas in situ, 10 severe dysplasias, and 15 mild/moderate dysplasias) compared with 1 of the 66 FV retained (FVR) biopsies. Molecular analysis on margins with low-grade or no dysplasia showed a significant association of LOH in FVL biopsies, with LOH at 3p and/or 9p (previously associated with local tumor recurrence) present in 12 of 19 FVL biopsies compared with 3 of 13 FVR biopsies (P = 0.04).

Conclusions: These data have, for the first time, shown that direct FV can identify subclinical high-risk fields with cancerous and precancerous changes in the operating room setting.


Commentary

Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem
William H. Westra and David Sidransky
Clin. Cancer Res. 2006 12: 6594-6597. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Journal of the American Dental AssociationHome page
J. B. Epstein, M. Gorsky, D. Fischer, A. Gupta, M. Epstein, and S. Elad
A Survey of the Current Approaches to Diagnosis and Management of Oral Premalignant Lesions
J Am Dent Assoc, December 1, 2007; 138(12): 1555 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Lippman and J. V. Heymach
The Convergent Development of Molecular-Targeted Drugs for Cancer Treatment and Prevention
Clin. Cancer Res., July 15, 2007; 13(14): 4035 - 4041.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. P ROSIN, C. F POH, M. GUILLARD, P MICHELE WILLIAMS, L. ZHANG, and C. MACAULAY
Visualization and Other Emerging Technologies as Change Makers for Oral Cancer Prevention
Ann. N.Y. Acad. Sci., March 1, 2007; 1098(1): 167 - 183.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. H. Westra and D. Sidransky
Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem.
Clin. Cancer Res., November 15, 2006; 12(22): 6594 - 6597.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.